MedTrace Logo

VITROS Immunodiagnostic Products hs Troponin I

NCT03581578 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1630

Last updated 2020-09-16

No results posted yet for this study

Summary

The purpose of this clinical study is to collect data to substantiate the use of the VITROS hs Troponin I test as an aid in the diagnosis of myocardial infarction (MI). The test is further indicated for risk stratification of mortality, myocardial infarction or coronary revascularization in patients with acute coronary syndrome.

Conditions

Sponsors & Collaborators

  • Ortho-Clinical Diagnostics, Inc.

    lead INDUSTRY

Principal Investigators

  • Fred Apple, PhD · Hennepin Healthcare Research Institute

  • Richard Nowak, MD · Henry Ford Health System

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-07
Primary Completion
2020-05-30
Completion
2021-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03581578 on ClinicalTrials.gov